Trevena Announces FDA Has Set PDUFA Date of August 7, 2020 for Oliceridine
FDA considers NDA resubmission a complete Class 2 responseUpdated guidance on extended cash runway, funding operations into Q1 2021CHESTERBROOK, Pa., […]
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call and Webcast on March 12, 2020
THE WOODLANDS, Texas, March 05, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter and […]
Nuance Gatekeeper Cloud-Native Biometrics Solution Named 2020 GLOMO Award Winner
BURLINGTON, Mass., March 05, 2020 (GLOBE NEWSWIRE) — Nuance®Communications, Inc. (NASDAQ: NUAN) today announced Nuance Gatekeeper, its AI-based biometrics solution […]
Idera Pharmaceuticals Completes Enrollment in ILLUMINATE-301, its Registrational Trial of Tilsotolimod in Combination with Ipilimumab in Patients with Anti-PD-1 Refractory Advanced Melanoma
EXTON, Pa., March 05, 2020 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or “the company”) (NASDAQ: IDRA) today announced completion […]
Plug Power Announces 2019 Fourth Quarter and Year End Results
LATHAM, N.Y., March 05, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling […]
Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™
RESEARCH TRIANGLE PARK, N.C., March 05, 2020 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical […]
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930
RESEARCH TRIANGLE PARK, N.C., March 05, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the first patients […]
Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results
CAMBRIDGE, Mass., March 05, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the […]
Axsome Therapeutics Announces the Promotion of Mark Jacobson to Chief Operating Officer
NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
Analytical Reference Materials Int’l Places Initial Order to Develop Certified Reference Material
MISSISSAUGA, Ontario, March 05, 2020 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company”) (TSX-V: CCB) is pleased to announce that […]
